Cargando…

The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta‐analysis

Ovarian cancer (OC) is the least survivable gynecological malignancy and presents late. Five‐year survival for OC is around 45% increasing the need for innovative treatments. Checkpoint inhibitors have shown significant clinical efficacy in mismatch repair deficient (MMRd) cancers and could be a pow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atwal, Amit, Snowsill, Tristan, Dandy, Marcus Cabrera, Krum, Thomas, Newton, Claire, Evans, Dafydd Gareth, Crosbie, Emma J., Ryan, Neil A. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Tumor Markers and Signatures
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539584/ https://www.ncbi.nlm.nih.gov/pubmed/35792468 http://dx.doi.org/10.1002/ijc.34165

Ejemplares similares

Protein Z: A putative novel biomarker for early detection of ovarian cancer
por: Russell, Matthew R., et al.
Publicado: (2016)

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022)

High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
por: Dent, Barry M., et al.
Publicado: (2015)

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

The WID‐qEC test: Performance in a hospital‐based cohort and feasibility to detect endometrial and cervical cancers
por: Schreiberhuber, Lena, et al.
Publicado: (2022)

High hemoglobin A1c levels within the non‐diabetic range are associated with the risk of all cancers
por: Goto, Atsushi, et al.
Publicado: (2015)

Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast‐screening
por: Murillo, Raúl, et al.
Publicado: (2015)

Validation of a DNA methylation HPV triage classifier in a screening sample
por: Lorincz, Attila T., et al.
Publicado: (2016)

The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016)

Distinct and shared three‐dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma
por: Sathitruangsak, Chirawadee, et al.
Publicado: (2016)

Epstein‐Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin
por: Ramayanti, Octavia, et al.
Publicado: (2016)

Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early‐stage melanoma
por: Ortega‐Martínez, Idoia, et al.
Publicado: (2016)

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
por: Stangl, Stefan, et al.
Publicado: (2017)

Whole blood FPR1 mRNA expression predicts both non‐small cell and small cell lung cancer
por: Morris, Scott, et al.
Publicado: (2018)

Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness
por: Zhao, Zhefu, et al.
Publicado: (2017)

Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
por: Kimbung, Siker, et al.
Publicado: (2017)

Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer
por: Bauer, Andrea S., et al.
Publicado: (2017)

Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
por: Belic, Jelena, et al.
Publicado: (2018)

Cancer‐associated fecal microbial markers in colorectal cancer detection
por: Eklöf, Vincy, et al.
Publicado: (2017)

Role of quantitative p16(INK4A) mRNA assay and digital reading of p16(INK4A) immunostained sections in diagnosis of cervical intraepithelial neoplasia
por: Vasiljević, Nataša, et al.
Publicado: (2017)

Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties
por: Eide, Peter W., et al.
Publicado: (2019)

Decreased RORC expression and downstream signaling in HTLV‐1‐associated adult T‐cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
por: Subramanian, Kritika, et al.
Publicado: (2018)

Vesicle‐bound EBV‐BART13‐3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV‐infections
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma
por: He, Weiling, et al.
Publicado: (2018)

Capturing colorectal cancer inter‐tumor heterogeneity in patient‐derived xenograft (PDX) models
por: Prasetyanti, Pramudita R., et al.
Publicado: (2018)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

Genome‐wide microRNA analysis of HPV‐positive self‐samples yields novel triage markers for early detection of cervical cancer
por: Snoek, Barbara C., et al.
Publicado: (2018)

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer
por: Leão, Ricardo, et al.
Publicado: (2018)

Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
por: Andree, Kiki C., et al.
Publicado: (2018)

Profiles of brain metastases: Prioritization of therapeutic targets
por: Ferguson, Sherise D., et al.
Publicado: (2018)

Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non‐small cell lung cancer (NSCLC)
por: Tang, Zhiyuan, et al.
Publicado: (2017)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2017)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
por: Haakensen, Vilde D., et al.
Publicado: (2020)

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
por: Vink, Frederique J., et al.
Publicado: (2019)

Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome
por: Lang, Michaela, et al.
Publicado: (2020)

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
por: Reduzzi, Carolina, et al.
Publicado: (2019)

Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
por: Akolkar, Dadasaheb, et al.
Publicado: (2019)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_je2ofsbast79if2r64n6ogfh28